🇺🇸 FDA
Patent

US 11097034

Compositions and methods of modulating endochondral ossification and bone formation

granted A61KA61K31/221A61K31/5578

Quick answer

US patent 11097034 (Compositions and methods of modulating endochondral ossification and bone formation) held by The Regents of the University of California expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/221, A61K31/5578, A61K35/28, A61K35/32